Melanocortin Receptor 4 Market Report

Global and Region Melanocortin Receptor 4 Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：200
  • REPORT CODE：GMM898783
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Melanocortin Receptor 4 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Melanocortin Receptor 4market, defines the market attractiveness level of Melanocortin Receptor 4 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Melanocortin Receptor 4 industry, describes the types of Melanocortin Receptor 4 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Melanocortin Receptor 4 market and the development prospects and opportunities of Melanocortin Receptor 4 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Melanocortin Receptor 4 market in Chapter 13.

    By Player:

    • Retrophin Inc

    • Pfizer Inc

    • Rhythm Pharmaceuticals, Inc

    • Mallinckrodt Plc

    • Palatin Technologies, Inc

    • Obexia AG

    • AstraZeneca Plc

    By Type:

    • Bremelanotide

    • Corticotropin

    • Cosyntropin

    • Others

    By End-User:

    • Metabolic Disorder

    • Women's Health

    • Genito Urinary System

    • Infection Disease

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Melanocortin Receptor 4 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Melanocortin Receptor 4 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Melanocortin Receptor 4 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Melanocortin Receptor 4 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Melanocortin Receptor 4 Market Analysis and Outlook to 2022

    • 7.1 Global Melanocortin Receptor 4 Consumption (2017-2022)

    • 7.2 United States Melanocortin Receptor 4 Consumption (2017-2022)

    • 7.3 Europe Melanocortin Receptor 4 Consumption (2017-2022)

    • 7.4 China Melanocortin Receptor 4 Consumption (2017-2022)

    • 7.5 Japan Melanocortin Receptor 4 Consumption (2017-2022)

    • 7.6 India Melanocortin Receptor 4 Consumption (2017-2022)

    • 7.7 South Korea Melanocortin Receptor 4 Consumption (2017-2022)

    8 Region and Country-wise Melanocortin Receptor 4 Market Analysis and Outlook to 2028

    • 8.1 Global Melanocortin Receptor 4 Consumption Forecast (2022-2028)

    • 8.2 United States Melanocortin Receptor 4 Consumption Forecast (2022-2028)

    • 8.3 Europe Melanocortin Receptor 4 Consumption Forecast (2022-2028)

    • 8.4 China Melanocortin Receptor 4 Consumption Forecast (2022-2028)

    • 8.5 Japan Melanocortin Receptor 4 Consumption Forecast (2022-2028)

    • 8.6 India Melanocortin Receptor 4 Consumption Forecast (2022-2028)

    • 8.7 South Korea Melanocortin Receptor 4 Consumption Forecast (2022-2028)

    9 Global Melanocortin Receptor 4 Market Outlook by Types and Applications to 2022

    • 9.1 Global Melanocortin Receptor 4 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Bremelanotide Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Corticotropin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Cosyntropin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Melanocortin Receptor 4 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Metabolic Disorder Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Women's Health Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Genito Urinary System Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Infection Disease Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Melanocortin Receptor 4 Market Outlook by Types and Applications to 2028

    • 10.1 Global Melanocortin Receptor 4 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Bremelanotide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Corticotropin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Cosyntropin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Melanocortin Receptor 4 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Metabolic Disorder Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Women's Health Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Genito Urinary System Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Infection Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Melanocortin Receptor 4 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Melanocortin Receptor 4 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Melanocortin Receptor 4 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Melanocortin Receptor 4 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Melanocortin Receptor 4 Market Competitive Analysis

    • 14.1 Retrophin Inc

      • 14.1.1 Retrophin Inc Company Details

      • 14.1.2 Retrophin Inc Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Retrophin Inc Melanocortin Receptor 4 Product and Service

    • 14.2 Pfizer Inc

      • 14.2.1 Pfizer Inc Company Details

      • 14.2.2 Pfizer Inc Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Inc Melanocortin Receptor 4 Product and Service

    • 14.3 Rhythm Pharmaceuticals, Inc

      • 14.3.1 Rhythm Pharmaceuticals, Inc Company Details

      • 14.3.2 Rhythm Pharmaceuticals, Inc Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Rhythm Pharmaceuticals, Inc Melanocortin Receptor 4 Product and Service

    • 14.4 Mallinckrodt Plc

      • 14.4.1 Mallinckrodt Plc Company Details

      • 14.4.2 Mallinckrodt Plc Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Mallinckrodt Plc Melanocortin Receptor 4 Product and Service

    • 14.5 Palatin Technologies, Inc

      • 14.5.1 Palatin Technologies, Inc Company Details

      • 14.5.2 Palatin Technologies, Inc Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Palatin Technologies, Inc Melanocortin Receptor 4 Product and Service

    • 14.6 Obexia AG

      • 14.6.1 Obexia AG Company Details

      • 14.6.2 Obexia AG Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Obexia AG Melanocortin Receptor 4 Product and Service

    • 14.7 AstraZeneca Plc

      • 14.7.1 AstraZeneca Plc Company Details

      • 14.7.2 AstraZeneca Plc Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 AstraZeneca Plc Melanocortin Receptor 4 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Melanocortin Receptor 4

    • Figure Melanocortin Receptor 4 Picture

    • Table Global Melanocortin Receptor 4 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Melanocortin Receptor 4 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Melanocortin Receptor 4 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Melanocortin Receptor 4 Consumption by Country (2017-2022)

    • Figure United States Melanocortin Receptor 4 Consumption and Growth Rate (2017-2022)

    • Table Europe Melanocortin Receptor 4 Consumption and Growth Rate (2017-2022)

    • Figure China Melanocortin Receptor 4 Consumption and Growth Rate (2017-2022)

    • Figure Japan Melanocortin Receptor 4 Consumption and Growth Rate (2017-2022)

    • Figure India Melanocortin Receptor 4 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Melanocortin Receptor 4 Consumption and Growth Rate (2017-2022)

    • Figure Global Melanocortin Receptor 4 Consumption Forecast by Country (2022-2028)

    • Figure United States Melanocortin Receptor 4 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Melanocortin Receptor 4 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Melanocortin Receptor 4 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Melanocortin Receptor 4 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Melanocortin Receptor 4 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Melanocortin Receptor 4 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bremelanotide Consumption and Growth Rate (2017-2022)

    • Figure Global Corticotropin Consumption and Growth Rate (2017-2022)

    • Figure Global Cosyntropin Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Metabolic Disorder Consumption and Growth Rate (2017-2022)

    • Figure Global Women's Health Consumption and Growth Rate (2017-2022)

    • Figure Global Genito Urinary System Consumption and Growth Rate (2017-2022)

    • Figure Global Infection Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Bremelanotide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Corticotropin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cosyntropin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Metabolic Disorder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Women's Health Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Genito Urinary System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infection Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Melanocortin Receptor 4 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Melanocortin Receptor 4 Export by Region (Top 5 Countries) (2017-2028)

    • Table Retrophin Inc (Foundation Year, Company Profile and etc.)

    • Table Retrophin Inc Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Retrophin Inc Melanocortin Receptor 4 Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Melanocortin Receptor 4 Product and Service

    • Table Rhythm Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Rhythm Pharmaceuticals, Inc Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rhythm Pharmaceuticals, Inc Melanocortin Receptor 4 Product and Service

    • Table Mallinckrodt Plc (Foundation Year, Company Profile and etc.)

    • Table Mallinckrodt Plc Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt Plc Melanocortin Receptor 4 Product and Service

    • Table Palatin Technologies, Inc (Foundation Year, Company Profile and etc.)

    • Table Palatin Technologies, Inc Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Palatin Technologies, Inc Melanocortin Receptor 4 Product and Service

    • Table Obexia AG (Foundation Year, Company Profile and etc.)

    • Table Obexia AG Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Obexia AG Melanocortin Receptor 4 Product and Service

    • Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Plc Melanocortin Receptor 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Plc Melanocortin Receptor 4 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US